Genscript Biotech Corp. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-1,170.00
-991.00
1,318.00
-3,380.00
-4,021.00
-2,181.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-16.00
668.00
-690.00
1,339.00
1,083.00
-94.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
2,622.00
659.00
-2,215.00
-955.00
-1,058.00
-1,110.00
Cash Flow from Investing Activities
-1,341.00
-11,405.00
-2,803.00
-3,487.00
-1,705.00
-785.00
Cash Flow from Financing Activities
-1,109.00
377.00
8,380.00
3,515.00
7,013.00
4,838.00
Net Cash Inflow / Outflow
184.00
-10,370.00
3,352.00
-1,026.00
4,243.00
2,971.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
14.00
-1.00
-9.00
-99.00
-6.00
28.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Genscript Biotech Corp.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-1170.61437456098
5271.39308385907
-6,441.00
-122.21%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-16.2859273980745
1234.2667660914
-1,250.00
-101.32%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
2622.33056060706
6566.08623859717
-3,944.00
-60.06%
Cash Flow from Investing Activities
-1341.65949046033
-4594.49975177798
3,253.00
70.80%
Cash Flow from Financing Activities
-1109.99236812372
-2719.54646633716
1,610.00
59.18%
Net Cash Inflow / Outflow
184.836310522235
-753.180875024643
937.00
124.54%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
14.1576084992357
-5.22089550667136
19.00
371.17%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 297.33% vs 129.79% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
2,622.33
659.98
297.33%






